Adamalizyny jako potencjalne biomarkery w wybranych nowotworach złośliwych przewodu pokarmowego
DOI: https://doi.org/10.2478/ahem-2021-0020 | Journal eISSN: 1732-2693
Language: English
Page range: 674 - 682
Submitted on: May 5, 2020
Accepted on: May 25, 2021
Published on: Oct 21, 2021
Published by: Hirszfeld Institute of Immunology and Experimental Therapy
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Related subjects:
© 2021 Magdalena Sikora-Skrabaka, Katarzyna Walkiewicz, Ewa Nowakowska-Zajdel, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.